藥品分銷市場規模、佔有率和成長分析：按產品類型、治療領域、分發類型、無菌性別、年齡層、配銷通路和地區分類 - 2026-2033 年行業預測

預計到 2024 年，全球配藥藥局市場規模將達到 160.8 億美元，到 2025 年將成長至 170.1 億美元，到 2033 年將成長至 267.1 億美元，在預測期（2026-2033 年）內複合年成長率為 5.8%。

受專利到期、人口老化和預期壽命延長等因素的推動，全球配製藥房市場預計將持續成長。配製藥房專注於根據患者的個別需求定製藥物，生產傳統製藥公司難以提供的獨特配製藥物。這些由持證專業人員配製的個人化藥物劑型多樣，包括調味液體、外用乳霜和凝膠，確保治療方案符合每位患者的特定需求。該市場主要面向成年人，提供營養補充品並治療由生活方式因素引起的慢性疾病。不良飲食習慣和久坐不動的生活方式導致慢性疾病日益普遍，預計將進一步增加對專業配製藥物的需求，從而推動市場成長。

推動全球配藥藥房市場發展的因素

全球配製藥房市場預計將迎來顯著成長，主要受口服藥物（如片劑和膠囊）日益普及的偏好。這一趨勢反映了口服藥物的廣泛接受度，尤其是在許多疾病只能透過口服給藥有效控制的情況下。隨著患者尋求便捷可靠的治療方案，對客製化口服藥物的需求持續成長，從而推動了市場擴張。醫療保健格局的不斷變化和創新口服製劑的研發進一步鞏固了這一上升趨勢，凸顯了口服藥物在現代醫學中的重要作用。

全球藥局市場面臨的限制因素

由於某些藥品監管日益嚴格，全球配藥局市場面臨嚴峻挑戰。監管機構正在實施限制某些藥物配製的措施，這影響了這些複雜藥物製劑的銷售。隨著禁令擴展到常用藥物，對常用配製藥品的需求可能會下降，導致配製藥房的市場機會萎縮。這種變化為製藥企業和藥劑師帶來了不確定性，他們必須在應對合規複雜性的同時，適應不斷變化的法規和消費者需求，並在日益嚴格的環境下維持永續的產品供應。

全球藥局市場趨勢

全球配製藥市場正經歷強勁成長，這主要得益於研發投入的激增，尤其是針對凝膠、乳膏和軟膏等創新型外用製劑的研發。在對個人化藥物和以患者為中心的解決方案日益成長的需求推動下，製藥公司正投入大量資源開發獨特且客製化的產品，以滿足特定的醫療需求。這一趨勢反映了醫療服務向個人化醫療的轉變，以及人們對配製藥益處的認知不斷提高。隨著醫療服務提供者和患者尋求更有效的治療方案，預計配製藥市場將繼續擴張，並充分利用製劑技術和個人化醫療的進步。

目錄

介紹

• 調查目標
• 市場定義和範圍

調查方法

• 調查過程
• 二手資料和一手資料方法
• 市場規模估算方法
• 市場假設與限制

執行摘要

• 全球市場展望
• 主要市場亮點
• 細分市場概覽
• 競賽概況

市場動態與展望

• 總體經濟指標
• 促進因素和機遇
• 限制與挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場考察

• 關鍵成功因素
• 影響市場的因素
• 關鍵投資機會
• 生態系測繪
• 市場吸引力指數（2025）
• PESTEL 分析
• 價值鏈分析
• 客戶和購買標準分析
• 案例研究
• 監管環境
• 專利分析

全球配藥藥房市場規模（按產品類型分類）（2019-2032 年）

• 口服
  • 膠囊
  • 藥片
  • 混合物
  • 棒糖
  • 錠劑
• 外用藥物
  • 凝膠
  • 軟膏
  • 奶油
  • 洗劑
• 直腸
• 鼻腔
• 眼科
• 其他

全球藥品分銷市場按治療領域分類（2019-2032 年）

• 荷爾蒙補充療法
• 疼痛管理
• 皮膚科
• 營養補充品
• 減重
• 其他

全球按配藥類型分類的配藥藥房市場規模（2019-2032 年）

• 藥品成分變更（PIA）
• 目前無法使用的藥品生產（CUPM）
• 藥物劑量調整（PDA）
• 其他

全球藥局市場規模（依無菌類型分類）（2019-2032 年）

• 無菌
• 非無菌

全球藥局市場按年齡層分類（2019-2032 年）

• 兒童
• 成人版
• 老年人

全球藥品分銷通路市場（2019-2032 年）

• 線上
• 離線
  • 配藥藥房
  • 醫院藥房
  • 其他

全球配藥藥房市場規模（按地區分類）（2019-2032 年）

• 北美（依產品類型、治療領域、製劑類型、無菌性別、年齡層、通路分類）
  • 美國
  • 加拿大
• 歐洲（依產品類型、治療領域、製劑類型、無菌性別、年齡層、通路分類）
  • 英國
  • 德國
  • 西班牙
  • 法國
  • 義大利
  • 其他歐洲地區
• 亞太地區（依產品類型、治療領域、製劑類型、無菌性別、年齡層及通路分類）
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲（依產品類型、治療領域、製劑類型、無菌性別、年齡層、通路分類）
  • 巴西
  • 墨西哥
  • 其他拉丁美洲地區
• 中東和非洲（按產品類型、治療領域、製劑類型、無菌性別、年齡層和分銷管道分類）
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭對手儀錶板

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）

主要企業簡介

• Becton, Dickinson and Company
• B. Braun Melsungen AG
• Fagron NV
• Fresenius Kabi AG
• McGuff Compounding Pharmacy Services Inc.
• Village Compounding Pharmacy
• Dougherty's Pharmacy, Inc.
• Institutional Pharmacy Solutions
• Walgreen Co.
• Triangle Compounding Pharmacy
• Custom Med Apothecary
• Olympia Pharmacy
• Precision Compounding Pharmacy
• College Pharmacy
• Rx3 Compounding Pharmacy
• Aurora Health Care
• Wedgewood Pharmacy
• Afrigen Biologics
• Albertsons Companies
• Formul8

結論和分析師建議

Global Compounding Pharmacy Market size was valued at USD 16.08 Billion in 2024 and is poised to grow from USD 17.01 Billion in 2025 to USD 26.71 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The Global Compounding Pharmacy Market is poised for growth, driven by factors such as patent expirations, an aging population, and increased life expectancy. Compounding pharmacies specialize in tailoring medications to meet individual patient needs, creating unique formulations that are often unavailable from traditional pharmaceutical companies. These personalized medications, crafted by licensed professionals, can take various forms including flavored liquids, topical creams, and gels, ensuring that treatment aligns with specific patient requirements. The market predominantly serves adults, offering nutritional supplements and addressing chronic conditions that arise from lifestyle choices. As chronic diseases become more prevalent, further fueled by poor dietary habits and sedentary lifestyles, the demand for specialized compounded medications is set to rise, propelling the market forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Compounding Pharmacy market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Compounding Pharmacy Market Segments Analysis

Global Compounding Pharmacy Market is segmented by Product Type, Therapeutic Area, Compounding Type, Sterility, Age Cohort, Distribution Channel and region. Based on Product Type, the market is segmented into Oral, Topical, Rectal, Nasal, Ophthalmic and Others. Based on Therapeutic Area, the market is segmented into Hormone replacement therapy, Pain management, Dermatology, Nutritional Supplements, Weight Loss and Others. Based on Compounding Type, the market is segmented into Pharmaceutical Ingredient Alteration (PIA), Currently Unavailable Pharmaceutical Manufacturing (CUPM), Pharmaceutical Dosage Alteration (PDA) and Others. Based on Sterility, the market is segmented into Sterile and Non Sterile. Based on Age Cohort, the market is segmented into Pediatric, Adult and Geriatric. Based on Distribution Channel, the market is segmented into Online and Offline. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Compounding Pharmacy Market

The Global Compounding Pharmacy market is expected to experience significant growth, fueled by the increasing preference for oral medications such as tablets and capsules. This trend reflects the broader acceptance of oral pharmaceuticals, particularly since many medical conditions can only be effectively managed through oral administration. As patients seek convenient and reliable treatment options, the demand for customized oral medications continues to rise, contributing to the expansion of the market. The evolving landscape of healthcare and the ongoing development of innovative oral formulations further support this upward trajectory, highlighting the pivotal role of oral pharmaceuticals in modern medical treatment.

Restraints in the Global Compounding Pharmacy Market

The global compounding pharmacy market faces significant challenges due to increasing restrictions on certain pharmaceuticals. Regulatory authorities have implemented measures that limit the compounding of specific medications, impacting the sales potential of these complex drug formulations. As prohibitions expand to include commonly used drugs, the demand for popular compounded medications may diminish, resulting in a decline in market opportunities for compounding pharmacies. This evolving landscape creates uncertainties for pharmaceutical manufacturers and pharmacists, who must adapt to changing regulations and consumer needs while navigating the complexities of compliance and maintaining a viable product offering in an increasingly restrictive environment.

Market Trends of the Global Compounding Pharmacy Market

The global compounding pharmacy market is experiencing robust growth driven by a surge in research and development focused on innovative topical formulations such as gels, creams, and ointments. With an increasing demand for personalized medication and patient-centric solutions, pharmaceutical companies are dedicating significant resources to develop unique and tailored products that address specific healthcare needs. This trend reflects a broader shift towards individualized treatments and the rising awareness of the benefits of compounded medications. As healthcare providers and patients alike seek more effective therapeutic options, the compounding pharmacy market is poised for continued expansion, leveraging advancements in formulation technology and personalized care.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Customer & Buying Criteria Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Compounding Pharmacy Market Size By Product Type (2019-2032)

• Market Overview
• Oral
  • Capsule
  • Tablets
  • Mixtures
  • Lollipops
  • Lozenges
• Topical
  • Gels
  • Ointments
  • Cream
  • Lotions
• Rectal
• Nasal
• Ophthalmic
• Others

Global Compounding Pharmacy Market Size By Therapeutic Area (2019-2032)

• Market Overview
• Hormone replacement therapy
• Pain management
• Dermatology
• Nutritional Supplements
• Weight Loss
• Others

Global Compounding Pharmacy Market Size By Compounding Type (2019-2032)

• Market Overview
• Pharmaceutical Ingredient Alteration (PIA)
• Currently Unavailable Pharmaceutical Manufacturing (CUPM)
• Pharmaceutical Dosage Alteration (PDA)
• Others

Global Compounding Pharmacy Market Size By Sterility (2019-2032)

• Market Overview
• Sterile
• Non Sterile

Global Compounding Pharmacy Market Size By Age Cohort (2019-2032)

• Market Overview
• Pediatric
• Adult
• Geriatric

Global Compounding Pharmacy Market Size By Distribution Channel (2019-2032)

• Market Overview
• Online
• Offline
  • Compounding Pharmacy
  • Hospital Pharmacy
  • Others

Global Compounding Pharmacy Market Size By Region (2019-2032)

• North America (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • US
  • Canada
• Europe (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Product Type, By Therapeutic Area, By Compounding Type, By Sterility, By Age Cohort, & By Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Dashboard

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025

Key Company Profiles

• Becton, Dickinson and Company
  • Company Overview
  • Product Portfolio Overview
  • Financial Overview
  • Key Developments
• B. Braun Melsungen AG
• Fagron NV
• Fresenius Kabi AG
• McGuff Compounding Pharmacy Services Inc.
• Village Compounding Pharmacy
• Dougherty's Pharmacy, Inc.
• Institutional Pharmacy Solutions
• Walgreen Co.
• Triangle Compounding Pharmacy
• Custom Med Apothecary
• Olympia Pharmacy
• Precision Compounding Pharmacy
• College Pharmacy
• Rx3 Compounding Pharmacy
• Aurora Health Care
• Wedgewood Pharmacy
• Afrigen Biologics
• Albertsons Companies
• Formul8

Conclusion & Analyst Recommendations